Literature DB >> 17169537

Retention of quinolones on human serum albumin and alpha1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity.

Francesco Barbato1, Giuseppina di Martino, Lucia Grumetto, Maria Immacolata La Rotonda.   

Abstract

The retention of 10 quinolone antibacterial agents on HPLC stationary phases supporting human serum albumin (HSA) or alpha(1)-acid glycoprotein (AGP) was investigated. Among ofloxacine and flumequine, the two chiral compounds in the selected set, only the latter showed a split chromatographic peak and only on HSA but not on AGP, indicating that enantioselective specific sites play only a minor role in the retention. The retention of quinolones, which included four acidic and six zwitterionic congeners, was correlated with various lipophilicity scales: (i) theoretically calculated values, clogP, (ii) values measured at pH 7.4 by the shake-flask method, logD(7.4), and (iii) values extrapolated by retention data measured by ion-pair reversed-phase high performance liquid chromatography (RP-HPLC). We assumed that the latter values, logP(i.p.), were close to the lipophilicity of the neutral forms, logP(N), for both acidic and zwitterionic congeners. No relationship was found between retention on serum proteins and clogP values, whereas a reasonable relationship was found with logD(7.4) values, but only when the two subclasses, acidic and zwitterionic congeners, were considered separately. The relationship between retention data on serum proteins and logP(i.p.) values indicated that the affinity for serum proteins depends on the lipophilicity of the neutral forms only for logP values up to 1.5. Above this value, protein retention does not further increase, becoming almost constant. Based on both the observations above reported and the small values of the slopes of regression equations, we conclude that the interaction of the more lipophilic quinolones, mainly the zwitterions, with serum proteins is not governed uniquely by lipophilicity but also by other mechanisms, probably of electrostatic nature.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169537     DOI: 10.1016/j.ejps.2006.11.004

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  3 in total

Review 1.  Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.

Authors:  David S Hage; Jeanethe Anguizola; Omar Barnaby; Abby Jackson; Michelle J Yoo; Efthimia Papastavros; Erika Pfaunmiller; Matt Sobansky; Zenghan Tong
Journal:  Curr Drug Metab       Date:  2011-05       Impact factor: 3.731

Review 2.  Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Authors:  David S Hage; Abby Jackson; Matthew R Sobansky; John E Schiel; Michelle J Yoo; K S Joseph
Journal:  J Sep Sci       Date:  2009-03       Impact factor: 3.645

3.  Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development.

Authors:  R Pignatello; T Musumeci; L Basile; C Carbone; G Puglisi
Journal:  J Pharm Bioallied Sci       Date:  2011-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.